Objectives Report my experience in treating two liver tumor patients with ketogenic diet KD protocol as monotherapy. In addition to the two patients who enrolled in this study, I also reviewed findings from 10 other patients, including 2 patients from case reports. Methods The ketogenic diet consists of high fat foods, foods that contain an adequate amount of protein, and a very low amount of carbohydrates. Normally, the body gets its main source of energy (sugar) from carbs. However, the ketogenic diet deprives the body of glucose, inducing a state of “ketosis.” During ketosis, the body is forced to break down stored fat instead of sugar to produce an alternative source of energy. Results The two patients who enrolled in my KD pilot study were monitored with twice daily measurements of blood glucose and ketones. Within 30 days of initiating the KD blood glucose levels declined to low-normal levels and blood ketones were elevated. Results of ultrasound images indicated that tumors has gone 1 year after KD. One patient exhibited significant clinical improvements during the study. All of these patients was treated using KD as monotherapy. No major side effects due to KD have been reported in any of these patients. They continued the ketogenic diet remaining free of disease progression. Conclusions I conclude that: 1. KD is safe and without major side effects; 2. ketosis can be induced using customary foods; 3. treatment with KD may be effective in controlling the progression of some liver cancer cells; 4. Maybe we can manipulate our own biological system a little bit or activate something we already have in place in order to more effectively combat cancer. Funding Sources DoTerra Science.
e J. R odrigues d a S ilva **S: t Como contribuição in icia l para o estudo das a n em ias n a s in fâ n cia , ap resen tam os o p resente trabalho, p arte de um program a de a v aliação das con d ições sa n itárias da in fân cia n a G u anab ara. Os A A . r e la ta m os a ch a d o s h em a to ló g ico s e m 100 cria n ça s, 96 ã a s q u a is se a p r e s e n ta v a m co m a n e m ia de diversos graus, se n d o 79% ferro p ên ica s, 2% m ac ro cítica s e 15% n o rm o crô m ica s, a m a io ria ã as quais a sso cm ã a s à h ip o p ro te in em ia , h a v e n d o c o n c o m itâ n c ia n o a u m e n to daOs ach ad os h em atológicos do san gue p e riférico de um g ru p o de 100 cria n ça s ab ri gadas n a F undação R om ão M attos D uarte, organização filan tróp ica d e s tin a d a à in te r nação de m enores aband onad os no Estado da G uanabara são apresentados a seguir, com os com entários das várias etap as que foram a n alisad as. MATERIAL No segundo grupo (quadros II-A e II-B ), estão as crian ças m aiores de 6 anos, num to ta l de 45 d oen tes. In icialm en te, apresen tam os a série verm elh a e, separadam en te (quadros III-A, III-B , IV-A e IV -B) os de m ais ach ad os h em a to ló g ico s nos p acientes. P ara a va lia çã o h em a to ló g ica RESULTADOS:No gru p o d e 1 a 6 an o s, encontram os 42 casos de an em ia hipocrôm ica (76,3% ), 10 casos de an em ia norm ocrôm ica (18,1%) e 2 casos de an em ia m acrocítica (3,6% ), com * T ra b a lh o d a C ad eira de C línica de D oenças T ro p ic a is e In fec tu o sas d a F a c u ld a d e de M edicina da U n iv e rsid a d e F e d e ra l do R io de Ja n e iro ** A ssisten tes P ro fe s so r C ated rático
Objectives This case is here to demonstrate the effectiveness of the Ketogenic Diet (KD) as adjunctive therapy in the treatment of oral fibrosarcoma tumor. Methods Brad, a five-year-old male mix-breed-dog was submitted on a ketogenic diet after mandibulectomy of the oral tumor. KD a high-fat/low-carbohydrate/adequate-protein diet has recently been proposed as adjuvant therapy in cancer treatment. KDs target the Warburg effect, a biochemical phenomenon in which cancer cells predominantly utilize glycolysis instead of oxidative phosphorylation to produce ATP; therefore, some cancers cannot metabolize ketone bodies, due to mitochondrial dysfunction and down-regulation of enzymes necessary for ketone utilization. Furthermore, by reducing blood glucose, insulin and insulin-like growth factor, the drivers of cancer cell proliferation, are also reduced in the bloodstream. Results This cancer, whose origin is a mesenchymal cell and consists of a malignant tumor of fibroblasts has a reported survival times after surgical excision ranging from 7.0 to 12.2 months. After eighteen months of dietary therapy, the tumor-associated inflammation was completely reduced, and no more lesions were found during clinical exams. The dog in this study showed significant improvement and came back to his normal life and activities right at the beginning of the therapy. Today, he has a healthy happy and very active life. Conclusions There are alternatives other than conventional medicine. The therapy plans must include diet either as an adjuvant or whenever possible as the main treatment. Nutrition plays an important role in the future of Medicine. Nontoxic metabolic therapy is effective, and those interested in cancer prevention should know about this. Although the study was managed in a dog, the ketogenic diet is effective in preventing and reducing cancer risks in humans. Integrative Medicine conducted with criteria and responsibility leads to health and vitality for patients. Funding Sources N/A. Supporting Tables, Images and/or Graphs
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.